Rudy Strijbos

Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library

Peggy Geluykens, M. Van Loock, B. Devogelaere, 2017, Antiviral research.

Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

K. Hertogs, Peggy Geluykens, Inge Vereycken, 2008, Journal of Virology.

Design, Synthesis, and Biological Evaluation of Novel Indoles Targeting the Influenza PB2 Cap Binding Region.

Christophe Buyck, J. Grimes, J. Keown, 2019, Journal of medicinal chemistry.